HCAT vs EVH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

HCAT

38.7
AI Score
VS
HCAT Wins

EVH

33.9
AI Score

Investment Advisor Scores

HCAT

39score
Recommendation
SELL

EVH

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT EVH Winner
Forward P/E 7.764 24.0964 HCAT
PEG Ratio 0 1.9281 Tie
Revenue Growth -12.7% 46.9% EVH
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 38.7/100 33.9/100 HCAT
Profit Margin -90.6% -24.1% EVH
Beta 1.00 1.00 Tie
AI Recommendation SELL EXTENDED EVH

Relative Price Performance (Last 90 Days)

HCAT 1M: -23.9% · 3M: +18.6% EVH 1M: +2.2% · 3M: +23.4%

Current Technical Phase

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 32.4 · Price: $1.53

EVH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.2 · Price: $4.74

Fundamentals Snapshot

Metric HCAT EVH
Market Cap
Forward P/E 38.4 12.1
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.5%
Gross Margin 0.5% 0.2%
Operating Margin -0.1% 0.0%
EPS -3.54 -4.49
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.